| Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of … MS Silverberg, J Satsangi, T Ahmad, IDR Arnott, CN Bernstein, SR Brant, ... Canadian Journal of Gastroenterology and Hepatology 19, 5A-36A, 2005 | 4128 | 2005 |
| A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 C Gasche, J Scholmerich, J Brynskov, G D'Haens, SB Hanauer, EJ Irvine, ... Inflammatory bowel diseases 6 (1), 8-15, 2000 | 1544 | 2000 |
| European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis EF Stange, SPL Travis, S Vermeire, C Beglinger, L Kupcinkas, K Geboes, ... Gut 55 (suppl 1), i1-i15, 2006 | 882 | 2006 |
| Iron, anaemia, and inflammatory bowel diseases C Gasche, MCE Lomer, I Cavill, G Weiss Gut 53 (8), 1190-1197, 2004 | 724 | 2004 |
| European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases AU Dignass, C Gasche, D Bettenworth, G Birgegård, S Danese, ... Journal of Crohn's and Colitis 9 (3), 211-222, 2015 | 666 | 2015 |
| Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases# C Gasche, A Berstad, R Befrits, C Beglinger, A Dignass, K Erichsen, ... Inflammatory bowel diseases 13 (12), 1545-1553, 2007 | 626 | 2007 |
| FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease R Evstatiev, P Marteau, T Iqbal, IL Khalif, J Stein, B Bokemeyer, ... Gastroenterology 141 (3), 846-853. e2, 2011 | 480 | 2011 |
| A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT®) randomized controlled trial S Kulnigg, S Stoinov, V Simanenkov, LV Dudar, W Karnafel, LC Garcia, ... Official journal of the American College of Gastroenterology| ACG 103 (5 …, 2008 | 475 | 2008 |
| Systematic review: managing anaemia in Crohn's disease S Kulnigg, C Gasche Alimentary pharmacology & therapeutics 24 (11‐12), 1507-1523, 2006 | 473 | 2006 |
| Iron sensing and signalling R Evstatiev, C Gasche Gut 61 (6), 933-952, 2012 | 382 | 2012 |
| Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ H Tilg, C Van Montfrans, A Van den Ende, A Kaser, SJH Van Deventer, ... Gut 50 (2), 191-195, 2002 | 324 | 2002 |
| Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease S Schreiber, S Howaldt, M Schnoor, S Nikolaus, J Bauditz, C Gasché, ... New England Journal of Medicine 334 (10), 619-624, 1996 | 295 | 1996 |
| Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease C Gasche, G Moser, K Turetschek, E Schober, P Moeschl, G Oberhuber Gut 44 (1), 112-117, 1999 | 276 | 1999 |
| Management of iron deficiency anemia K Jimenez, S Kulnigg-Dabsch, C Gasche Gastroenterology & hepatology 11 (4), 241, 2015 | 268 | 2015 |
| Dietary guidance from the international organization for the study of inflammatory bowel diseases A Levine, JM Rhodes, JO Lindsay, MT Abreu, MA Kamm, PR Gibson, ... Clinical Gastroenterology and Hepatology 18 (6), 1381-1392, 2020 | 249 | 2020 |
| Intravenous iron and erythropoietin for anemia associated with Crohn disease: a randomized, controlled trial C Gasche, C Dejaco, T Waldhoer, W Tillinger, W Reinisch, GF Fueger, ... Annals of internal medicine 126 (10), 782-787, 1997 | 238 | 1997 |
| Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse W Reinisch, C Gasché, W Tillinger, J Wyatt, C Lichtenberger, M Willheim, ... Official journal of the American College of Gastroenterology| ACG 94 (8 …, 1999 | 214 | 1999 |
| Anemia in IBD: the overlooked villain C Gasche Inflammatory bowel diseases 6 (2), 142-150, 2000 | 211 | 2000 |
| Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study B Favrat, K Balck, C Breymann, M Hedenus, T Keller, A Mezzacasa, ... PloS one 9 (4), e94217, 2014 | 208 | 2014 |
| A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells A Goel, DK Chang, L Ricciardiello, C Gasche, CR Boland Clinical Cancer Research 9 (1), 383-390, 2003 | 202 | 2003 |
